Percheron Therapeutics LimitedASX: PER

Manufacture of ATL1102 clinical supplies for Phase IIb trial

May 26, 2021 at 4:10 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment